Product Information
CARBIDOPA-LEVO ER 25-100 TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.1156 per EA under NDC 16729007801. Its NADAC has been published 548 times since Nov 28, 2013.
FDA first approved this application on Feb 8, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 100 mg/1; mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729007801
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA202323FDA Approved
2/8/2013
TE Code
AB
On Market Since
6/13/2013
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVO ER 25-100 TAB has been published 548 times since Nov 28, 2013, and over the history we have for it it has declined 57.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1156 per EA |
|---|---|
| All-time high | $0.3892 (May 13, 2015) |
| All-time low | $0.1048 (Nov 20, 2024) |
| 52-week high | $0.1349 |
| 52-week low | $0.1101 |
| Median price | $0.2291 |
| Average price | $0.2238 |
| Largest weekly change | +35.9% (Jan 17, 2018) |
| Weeks tracked | 548 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+3.5%
1Y
-14.3%
3Y
-25.3%
5Y
-40.4%
All
-57.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVO ER 25-100 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO ER 25-100 TAB, manufactured by Accord Healthcare Inc., is $0.1156 per EA (NDC 16729007801), effective May 20, 2026.
How has the price of CARBIDOPA-LEVO ER 25-100 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVO ER 25-100 TAB has declined 57.6%. It has been tracked across 548 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO ER 25-100 TAB?
Since Nov 28, 2013, the NADAC for CARBIDOPA-LEVO ER 25-100 TAB has ranged from a low of $0.1048 (Nov 20, 2024) to a high of $0.3892 (May 13, 2015), with a median of $0.2291 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVO ER 25-100 TAB?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBIDOPA-LEVODOPA 25-100 TAB, is $0.0766 per EA — about 34% below CARBIDOPA-LEVO ER 25-100 TAB.
Who manufactures CARBIDOPA-LEVO ER 25-100 TAB?
CARBIDOPA-LEVO ER 25-100 TAB (NDC 16729007801) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.